Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance

BACKGROUND: While BMPR2 mutation strongly predisposes to pulmonary arterial hypertension (PAH), only 20% of mutation carriers develop clinical disease. This finding suggests that modifier genes contribute to FPAH clinical expression. Since modifiers are likely to be common alleles, this problem is n...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: West, James, Cogan, Joy, Geraci, Mark, Robinson, Linda, Newman, John, Phillips, John A, Lane, Kirk, Meyrick, Barbara, Loyd, Jim
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2008
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2561034/
https://ncbi.nlm.nih.gov/pubmed/18823550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-1-45
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы